ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

17,839Medicare Part D Prescriptions Filled, Including Refills

Rank: 85 out of 2588

$985K Total Retail Price of All Prescriptions

Rank: 92 out of 2588

651 Patients Receiving at Least One Drug in Part D
86%Patients 65 Years and Older
33% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Illinois
Lower avg

Schedule Two
Controlled Substances

4% of this provider’s 651 patients filled at least one prescription for a schedule two drug, compared to an average of 1%.

Schedule Three
Controlled Substances

21% of this provider’s 651 patients filled at least one prescription for a schedule three drug, compared to an average of 11%.

Risky Drugs to Seniors

2% of this provider’s 15,336 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

22% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$55 was the average price of a prescription from this provider, compared to $60 among peers.

Prescriptions per Patient

27 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Illinois
SIMVASTATIN 789 655 1 1
AMLODIPINE BESYLATE 719 676 2 4
ATENOLOL 688 605 3 14
OMEPRAZOLE 605 540 4 6
HYDROCODONE-ACETAMINOPHEN 529 328 S3 5 7
LEVOTHYROXINE SODIUM 505 430 6 2
LISINOPRIL 473 394 7 3
METOPROLOL SUCCINATE 399 367 8 12
WARFARIN SODIUM 383 336 9 10
FUROSEMIDE 335 318 10 5
HYDROCHLOROTHIAZIDE 308 295 11 13
ZOLPIDEM TARTRATE 305 247 12 24
METOPROLOL TARTRATE 285 276 13 9
TAMSULOSIN HCL 269 257 14 23
AMLODIPINE BESYLATE-BENAZEPRIL 266 249 15 76
SERTRALINE HCL 264 216 16 26
ATORVASTATIN CALCIUM 253 233 17 11
METFORMIN HCL 245 187 18 8
GABAPENTIN 203 161 19 18
AZITHROMYCIN 202 165 20 45
DONEPEZIL HCL 201 201 21 22
LOSARTAN POTASSIUM 198 192 22 17
POTASSIUM CHLORIDE 186 182 23 15
HYDRALAZINE HCL 179 164 24 53
LISINOPRIL-HYDROCHLOROTHIAZIDE 160 135 25 35
PRAVASTATIN SODIUM 155 152 26 16
FENOFIBRATE 155 150 26 64
FLUTICASONE PROPIONATE 145 116 28 40
CARVEDILOL 144 133 29 20
LOSARTAN-HYDROCHLOROTHIAZIDE 136 129 30 66
LOVASTATIN 135 119 31 34
GLYBURIDE 134 130 R 32 65
OXYBUTYNIN CHLORIDE ER 124 111 33 85
DIOVAN 121 108 34 29
BUMETANIDE 121 113 34 117
CRESTOR 117 110 36 25
CITALOPRAM HBR 115 106 37 27
BENAZEPRIL HCL 115 110 37 84
MELOXICAM 109 101 39 51
LANTUS 108 75 40 47
CIPROFLOXACIN HCL 103 89 41 82
PROAIR HFA 100 67 42 50
CLOPIDOGREL 98 90 43 30
NIFEDIPINE ER 95 91 44 59
ALLOPURINOL 93 76 45 33
PANTOPRAZOLE SODIUM 91 83 46 28
KLOR-CON 10 87 84 47 75
NEXIUM 87 52 47 41
ADVAIR DISKUS 85 78 49 48
ALENDRONATE SODIUM 85 85 49 21
TERAZOSIN HCL 84 84 51 137
PREDNISONE 83 77 52 42
NAMENDA 82 82 53 32
TRAMADOL HCL 81 72 54 19
IPRATROPIUM-ALBUTEROL 76 69 55 104
RISPERIDONE 72 72 56 57
METFORMIN HCL ER 72 71 56 67
DIOVAN HCT 71 71 58 72
BUPROPION XL 71 70 58 256
MIRTAZAPINE 70 70 60 63
ESCITALOPRAM OXALATE 68 57 61 68
FINASTERIDE 66 66 62 97
PLAVIX 65 60 63 43
CARBIDOPA-LEVODOPA 64 64 64 83
AMOX TR-POTASSIUM CLAVULANATE 64 51 64 131
MECLIZINE HCL 63 54 66 120
ISOSORBIDE MONONITRATE ER 60 54 67 49
HYDROXYZINE HCL 60 53 R 67 194
TRIAMTERENE-HCTZ 60 43 67 46
LEVOFLOXACIN 59 42 70 77
METHOCARBAMOL 59 27 R 70 303
AMOXICILLIN 57 49 72 130
MIDODRINE HCL 57 42 72 365
TRIAMCINOLONE ACETONIDE 56 42 74 106
LIPITOR 54 42 75 114
NIFEDICAL XL 53 44 76 179
NYSTATIN-TRIAMCINOLONE 51 45 77 158
DIPHENOXYLATE-ATROPINE 51 28 77 331
DIGOXIN 51 47 77 38
INSULIN SYRINGE 51 42 77 81
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Dec. 17, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.